<code id='E22E0A7018'></code><style id='E22E0A7018'></style>
    • <acronym id='E22E0A7018'></acronym>
      <center id='E22E0A7018'><center id='E22E0A7018'><tfoot id='E22E0A7018'></tfoot></center><abbr id='E22E0A7018'><dir id='E22E0A7018'><tfoot id='E22E0A7018'></tfoot><noframes id='E22E0A7018'>

    • <optgroup id='E22E0A7018'><strike id='E22E0A7018'><sup id='E22E0A7018'></sup></strike><code id='E22E0A7018'></code></optgroup>
        1. <b id='E22E0A7018'><label id='E22E0A7018'><select id='E22E0A7018'><dt id='E22E0A7018'><span id='E22E0A7018'></span></dt></select></label></b><u id='E22E0A7018'></u>
          <i id='E22E0A7018'><strike id='E22E0A7018'><tt id='E22E0A7018'><pre id='E22E0A7018'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:467
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          First Opinion on colorectal cancer screening: letter and response
          First Opinion on colorectal cancer screening: letter and response

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutdifficultissues,STATpublishesselected

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          First Opinion on colorectal cancer screening: letter and response

          MollyFergusonforSTATToencouragerobust,good-faithdiscussionaboutdifficultissues,STATpublishesselected